Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study
Although not statistically significant, predictors of increased acceptability provide information to tailor strategies to increase HPV vaccination coverage and accelerate progress toward cervical cancer elimination.
Authors
- Bryan J. Weiner (ORCID: https://orcid.org/0000-0002-6996-9480)
- Lucy Mecca
- Grace Umutesi (ORCID: https://orcid.org/0000-0001-5932-3187)
- Lynda Oluoch (ORCID: https://orcid.org/0000-0002-3105-8892)
- Elizabeth A. Bukusi (ORCID: https://orcid.org/0000-0002-2031-2808)
- Ruanne V. Barnabas (ORCID: https://orcid.org/0000-0002-1793-6003)
- Nelly Mugo (ORCID: https://orcid.org/0000-0002-2347-006X)
- Kenneth Ngure (ORCID: https://orcid.org/0000-0002-8062-0933)
- Maricianah Onono (ORCID: https://orcid.org/0000-0001-6847-8762)
- Betty Njoroge
Institutions
- Harvard University (US)
- University of Washington (US)
- Jomo Kenyatta University of Agriculture and Technology (KE)
- Kenya Medical Research Institute (KE)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JNCI Monographs
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/jncimonographs/lgae031
- Citations
- 3
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Bill and Melinda Gates Foundation